When we examined immunosuppressive lipid shedding by breast cancers, we found that treatment of breast cancer cell lines and Brca-1 mutant mice with Lipitor restored anti-tumor immune responses and decreased mammary hyperplasia in vivo. This evidence concerns the gene BRCA1 and neoplasm.